This inventor holds 1 USPTO granted patent. Top assignee: Korro Bio, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Tyson Moyer and RNA-Editing Innovation.
Introduction
Tyson Moyer is an inventor based in Cambridge, Massachusetts. His patent work includes research into oligonucleotides designed for RNA editing, an approach aimed at modifying RNA rather than DNA.
Latest Patents
Moyer is associated with one patent: RNA-Editing Oligonucleotides and Uses Thereof. The patent concerns oligonucleotides and their potential applications in RNA editing. The available information does not establish its filing or grant date. His reported portfolio includes 1 patent.
Career Highlights
Moyer is associated with Korro Bio, Inc., a biotechnology company focused on RNA editing. His listed patent connects his inventive work with this area of biotechnology.
Collaborations
Moyer’s listed coworkers include Venkat Krishnamurthy and Christopher Brown. Their inclusion indicates professional connections, but the available information does not specify their roles in the patent or related research.
Conclusion
Tyson Moyer’s patent activity reflects an association with RNA-editing oligonucleotide technology and Korro Bio, Inc., highlighting his connection to innovation in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile